Conversely, in advanced cancers, TGF‐β induces reprogramming of intracellular amino acid metabolism, promoting the acquisition of a mesenchymal phenotype in NSCLC cells, thus driving metastatic disease.152. Here, TGFB1 is linked to cancer.